Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Mecasermin rinfabate

EU orphan designation number: EU/3/06/378
Active ingredient: Mecasermin rinfabate
Indication: Treatment of primary insulin-like growth factor-1 deficiency due to molecular or genetic defects
Sponsor: Insmed Europe Ltd.
5 Percy Street, Office 4, London W1T 1DG, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2006 Centralised Orphan - Designation EMEA/OD/029/06 (2006)2907 of 20/06/2006
10/11/2006 Other procedure
08/05/2007 Centralised Orphan - Removal of orphan designation from Community Register